http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111596055-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d518a55fb8b7afa2d1990418e5e594e9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2509-10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0694 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 |
| filingDate | 2020-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b4a41d2bd6c9f2c5d1aeafe12d384bc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea6a5539db9244b02cf09eeec7ba335d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7319572d353a96d756b53208c1d60893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2e3d84283eaba98c1c75aca7d497f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c8c845d06727a468eb37cb405555be7 |
| publicationDate | 2020-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111596055-A |
| titleOfInvention | An immunofluorescence kit and detection method for detecting AR-V7 expression in peripheral blood circulating tumor cells of patients with prostate cancer |
| abstract | The invention discloses an immunofluorescence kit and a detection method for detecting the expression of AR-V7 in peripheral blood circulating tumor cells of prostate cancer patients. % goat serum, primary antibody suspension composed of mouse anti-CK, rat anti-CD45 and rabbit anti-AR-V7, fluorescently labeled goat anti-mouse, fluorescently labeled goat anti-rat, fluorescently labeled goat anti-rabbit The secondary antibody suspension and DAPI mounting medium; the detection method includes peripheral blood collection, membrane filtration separation, staining, determination of the presence of CTCs, and detection of AR-V7 expression in peripheral blood CTCs by immunofluorescence. The method provided by this patent can detect the expression of AR-V7 in patients with advanced or recurrent prostate cancer without obtaining tissue samples by needle biopsy, and can realize real-time dynamic detection by using minimally invasive technology. |
| priorityDate | 2020-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.